Questionable “Young Blood” Transfusions Offered in U.S. as Anti-Aging Remedy

Just off a winding highway along the Pacific coast in Monterey, California, is a private clinic where people can pay $8,000 to have their veins pumped with blood plasma from teenagers and young adults.

Jesse Karmazin is the entrepreneur who made the practice possible, by launching a clinical trial on the potential of “young blood” through his startup Ambrosia. He says that within a month, most participants “see improvements” from the one-time infusion of a two-liter bagful of plasma, which is blood with the blood cells removed.

Several scientists and clinicians say Karmazin’s trial is so poorly designed it cannot hope to provide evidence about the effects of the transfusions. And some say the pay-to-participate study, with the potential to collect up to $4.8 million from as many as 600 participants, amounts to a scam.

Read more: Questionable “Young Blood” Transfusions Offered in U.S. as Anti-Aging Remedy

Don’t forget to share this via , , Google+, Pinterest, LinkedIn, Buffer, , Tumblr, Reddit, StumbleUpon and Delicious.

Mike Rawson

Mike Rawson has recently re-awoken a long-standing interest in robots and our automated future.

He lives in London with a single android – a temperamental vacuum cleaner – but is looking forward to getting more cyborgs soon.

Leave a Reply

Your email address will not be published. Required fields are marked *

Questionable “Young Blood” Transfusions Offered in U.S. as Anti-Ag…

by Mike Rawson time to read: 1 min
Hi there - can I help you with anything?
[Subscribe here]
 
More in Man v Robot, News
CES 2017 hype
VR and wearable tech struggle to live up to the hype at CES 2017

The Consumer Electronics Show in Las Vegas attracts thousands of exhibitors and attendees searching for the next big thing, with...

Close